Mutual of America Capital Management LLC lessened its holdings in shares of Revvity, Inc. (NYSE:RVTY – Free Report) by 3.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,544 shares of the company’s stock after selling 618 shares during the period. Mutual of America Capital Management LLC’s holdings in Revvity were worth $1,630,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Czech National Bank boosted its position in Revvity by 0.5% during the 1st quarter. Czech National Bank now owns 21,713 shares of the company’s stock worth $2,280,000 after acquiring an additional 99 shares during the period. Garrison Asset Management LLC lifted its holdings in Revvity by 0.5% in the second quarter. Garrison Asset Management LLC now owns 21,328 shares of the company’s stock worth $2,236,000 after purchasing an additional 103 shares during the period. TriaGen Wealth Management LLC grew its position in Revvity by 2.3% in the 2nd quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company’s stock valued at $500,000 after buying an additional 107 shares in the last quarter. Guinness Asset Management LTD grew its position in Revvity by 3.3% in the 2nd quarter. Guinness Asset Management LTD now owns 3,587 shares of the company’s stock valued at $376,000 after buying an additional 116 shares in the last quarter. Finally, Inspire Investing LLC increased its stake in Revvity by 2.9% during the 1st quarter. Inspire Investing LLC now owns 4,190 shares of the company’s stock valued at $440,000 after buying an additional 117 shares during the period. 86.65% of the stock is owned by institutional investors.
Insider Buying and Selling at Revvity
In related news, insider Joel S. Goldberg sold 3,500 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the completion of the sale, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.60% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on RVTY
Revvity Stock Performance
Shares of Revvity stock opened at $126.34 on Friday. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $128.15. The company has a quick ratio of 1.98, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The stock has a market cap of $15.59 billion, a PE ratio of 104.41, a price-to-earnings-growth ratio of 2.90 and a beta of 1.05. The business has a fifty day simple moving average of $119.75 and a 200-day simple moving average of $110.91.
Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Monday, July 29th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. The firm had revenue of $691.70 million during the quarter, compared to analyst estimates of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The business’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same period last year, the company posted $1.21 EPS. On average, sell-side analysts anticipate that Revvity, Inc. will post 4.75 EPS for the current fiscal year.
Revvity Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.22%. Revvity’s payout ratio is 23.14%.
About Revvity
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Read More
- Five stocks we like better than Revvity
- Industrial Products Stocks Investing
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Conference Calls and Individual Investors
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- What Are the FAANG Stocks and Are They Good Investments?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.